It was stated (Scott, I964) that a live trachoma vaccine had no clear-cut effect in cases of severe trachoma although there were encouraging results in patients with mild trachoma and in a volunteer. This paper, which describes a further study supported by statistical analysis carried out on 553 children over a period of 5 years, confirms that no clear-cut benefit was obtained from the use of a live trachoma vaccine in cases of severe trachoma.
A school for 300 native Bantu children aged from 7 to 15 years was selected in the Northern Transvaal where classical trachoma was known to be common. Attendance at school was not compulsory and only 193 were present at the first examination in i965 by Scott and Pienaar, who reached agreement on their findings, each using a loupe in daylight. Pannus of 2 to 3 mm. and Herbert's pits were found in 48 of the first fifty children examined, after which these signs were ignored. The upper lid was everted and three abnormal signs were commonly found.: (I) Follicles (2) Hyperaemia (3) Hyperplasia of the tarsal conjunctiva.
These were not necessarily regarded as signs of trachoma but each was given a figure to represent severity as described later by the statistician. Of the I93 children, I 13 had signs of active infection, nineteen had scars in a quiet eye, and 4I had a normal tarsal conjunctiva.
In the following 3 years, the new intakes of I I I, 126 and I23 children were examined and the old cases re-examined by the same two ophthalmologists. Swabs for TRIC culture were positive in 9I of 98 unselected children in I965; this high proportion of positives fell to 55, 28, and 8 per cent. in the three successive intakes although the incidence of trachoma and the average point score were much the same in each group. Cultures were done by Mrs. Cuthbertson and Miss Ryan at the South African Institute for Medical Research.
Another curious feature was that a higher proportion of positive cultures came from those with lower total scores (e.g. 3, 2, or i). In each intake there were one or two carriers, i.e. patients with a normal tarsal conjunctiva who yielded TRIC agent on culture but had a total score of o.
A live trachoma vaccine (E.I.D. iO-3), prepared at the South African Institute for Medical Research under the direction of Prof. J. H. S. Gear, was given by subcutaneous injection to onethird of the children selected by random numbers. Each vaccinated child was given a second dose a month later and a booster dose each subsequent year. If a patient was absent when the vaccinations took place, every effort was made to give the vaccine at the earliest opportunity and nearly all of the selected children received their quota of vaccine. There was only one case of reaction (allergic oedema). As practically every child in that area contracted trachoma by the age of I year it was decided to treat all scholars (irrespective of initial score) with I per cent. tetracycline ointment once daily during their first school year in the hope that the vaccine would prevent reinfection when treatment was stopped.
A total of 552 children was examined and I84 were given vaccine. An analysis of the results is given below. The response to therapy will be the subject of another communication.
j. Graham Scott and J. E. Kerrich Statistical report on the findings There are two basic groups of patients: those who received the vaccine and those who did not.
Each child was examined from time to time and the severity of each of three signs was noted on a four-point scale: o, I, 2, 3. The sum of these three scores, which can vary from o to 9, is takeni as an overall indication of the severity of the disease at a given time. Two typical results are shown in Table I . If observations are missing, it was not possible to find the child on a given date for re-examination. Figure, for those who received the vaccine and those who did not. These two subgroups are logically comparable. When comparing them, either from the table or from the graphs, one would like to see that the mean scores for those vaccinated are smaller than the scores for those not vaccinated, and to see these differences steadily increase as time goes on. This would be evidence that the vaccine helps. But the differences vary in an erratic manner. Furthermore, the estimated standard deviations of the individual differences are so large that no sound statistical evidence exists for judging whether or not any particular "true" difference is positive or negative.
Live trachoma vaccine and topical therapy Many such comparable pairs of subgroups exist and their mean scores were tabulated and graphed. In all cases the two graphs intertwined erratically in much the same way as in the Figure. Table II The disadvantage of having so many comparable pairs of subgroups is that the number of observations in each is small. But any method that can be evolved for combining these subgroups into two large subgroups and comparing them, with the idea of using a statistically more powerful test of the effectsofvaccination, necessitates making various assumptions before the comparison can be regarded as valid. These assumptions we are not prepared to make.
In conclusion, then, with the evidence arranged in Tables such as Table II , our judgement is that the vaccine did not help the patients at all.
